The commercialization of genome-editing technologies

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Critical Reviews in Biotechnology

• Publication date

  2017-01-18

• Fields of study

  Medicine, Business, Engineering

• Identifiers
  DOI 10.1080/07388551.2016.1271768PMID 28100080
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proceedings of the International Summit on Human Gene Editing: a global discussion—Washington, D.C., December 1–3, 2015

  2016cited by this paper
• How the US CRISPR patent probe will play out

  2016cited by this paper
• Patents in the time of CRISPR: Who owns gene editing?

  2016cited by this paper
• CRISPR: Pursuit of profit poisons collaboration

  2016cited by this paper
• Who Owns Gene Editing? Patents in the Time of CRISPR

  2016cited by this paper
• Second Chinese team reports gene editing in human embryos

  2016cited by this paper
• UK scientists gain licence to edit genes in human embryos

  2016cited by this paper
• The morality and ethics governing CRISPR–Cas9 patents in China

  2016cited by this paper
• The Impact of CRISPR/Cas9-Based Genomic Engineering on Biomedical Research and Medicine.

  2016cited by this paper
• Gene-edited CRISPR mushroom escapes US regulation

  2016cited by this paper
• The history and market impact of CRISPR RNA-guided nucleases.

  2015cited by this paper
• CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes

  2015cited by this paper
• Induction of targeted, heritable mutations in barley and Brassica oleracea using RNA-guided Cas9 nuclease

  2015cited by this paper
• The Regulatory Status of Genome‐edited Crops

  2015influential reference
• Chinese scientists genetically modify human embryos

  2015cited by this paper
• Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9.

  2014cited by this paper
• Who owns CRISPR-Cas9 in Europe?

  2014cited by this paper
• CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences

  2014cited by this paper
• The new frontier of genome engineering with CRISPR-Cas9

  2014cited by this paper
• Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects

  2014cited by this paper
• Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases

  2014cited by this paper
• Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells

  2014cited by this paper
• CRISPR-Cas system and method for altering expression of gene products

  2013cited by this paper
• Wasting cash—the decline of the British biotech sector

  2009cited by this paper
• Patent laws and innovation in China

  2009cited by this paper
• Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes

  2006cited by this paper
• The Universal Declaration on the Human Genome and Human Rights.

  2003cited by this paper
• Universal Declaration on the Human Genome and Human Rights, Unesco

  1997cited by this paper

• CRISPR/Cas system-mediated gene editing for disease resistance in food crops: current status and future directions

  2026cites this paper
• Opportunities to Strengthen Entrepreneurial Training in Undergraduate Biology Education

  2026cites this paper
• Forecasting (Nano)Medical Technologies: Lessons from the COVID-19 Pandemic for Science and Society

  2026cites this paper
• Charting exposomethics: a roadmap for the ethical foundations of the human exposome project

  2026cites this paper
• Innovation and Interdependence: Evidence from Gene-Editing Technology

  2025cites this paper
• Regulatory challenges and global trade implications of genome editing in agriculture

  2025cites this paper
• Science advising and democracy: Governing gene editing technologies.

  2025cites this paper
• Third-generation novel technologies for gene editing.

  2025cites this paper
• Threat or opportunity? A stakeholder perspective on country of origin brand and promoting gene edited foods

  2025cites this paper
• Intellectual property rights and plants made by new genomic techniques: Access to technology and gene-edited traits in plant breeding

  2024influential citation
• CRISPR/Cas Technology in Disease Prevention and Control of Aquatic Animals

  2024cites this paper
• Characterization of Research Support of Genome Editing Technologies and Transition to Clinical Trials

  2024cites this paper
• DYNAMICS OF GENOME EDITED PRODUCTS IN THE WORLD MARKET FOR FUTURE FOOD SECURITY : A REVIEW

  2024cites this paper
• CRISPR-Cas engineering in food science and sustainable agriculture: recent advancements and applications

  2023cites this paper
• CAR T cells and dendritic cells: vaccinomics perspectives

  2023cites this paper
• Advanced therapies and the Brexit process: emerging geographies of legal responsibilities and market opportunities

  2023cites this paper
• Ethical and legal implications of gene editing in plant breeding: a systematic literature review

  2023cites this paper
• Gene-editing technologies for developing climate resilient rice crops in sub-Saharan Africa: Political priorities and space for responsible innovation

  2023cites this paper
• Beyond the Genome: Genetically Modified Crops in Africa and the Implications for Genome Editing

  2023cites this paper
• La técnica CRISPR-Cas9 unos años después

  2022cites this paper
• Precision farming technologies in vegetable growing

  2022cites this paper
• Perspectives of genome editing in humans: risks, problems and legal regulation

  2022cites this paper
• The socio-economic factors affecting the emergence and impacts of new genomic techniques in agriculture: A scoping review

  2022cites this paper
• Addressing Conflicts of Interest and Conflicts of Commitment in Public Advocacy and Policy Making on CRISPR/Cas-Based Human Genome Editing

  2022cites this paper
• Implicit and Explicit Attitudes toward Foods Derived from Genome Editing and Genetic Modification Technologies under Different Information Treatments

  2022cites this paper
• Communicating CRISPR: Challenges and opportunities in engaging the public.

  2022cites this paper
• Consumer Valuation of and Attitudes towards Novel Foods Produced with New Plant Engineering Techniques: A Review

  2021cites this paper
• The CRISPR revolution and its potential impact on global health security

  2021cites this paper
• In vivo Genome Editing Therapeutic Approaches for Neurological Disorders: Where Are We in the Translational Pipeline?

  2021cites this paper
• Expert opinions on the regulation of plant genome editing

  2021cites this paper
• Patents and technology transfer in CRISPR technology.

  2021cites this paper
• Patents, ethics, biosafety and regulation using CRISPR technology.

  2021cites this paper
• The challenges and considerations for emerging or future entrepreneurial researchers in microphysiological systems

  2021cites this paper
• Genetically modified crop regulations: scope and opportunity using the CRISPR-Cas9 genome editing approach

  2021cites this paper
• The CRISPR Patent Landscape: Focus on Chinese Researchers

  2021cites this paper
• Fourth generation biofuel from genetically modified algal biomass: Challenges and future directions.

  2021cites this paper
• Food System Innovations and Digital Technologies to Foster Productivity Growth and Rural Transformation

  2021cites this paper
• Consumer Valuation of and Attitudes Towards Novel Foods Produced with NPETs: A Review

  2021cites this paper
• Correcting Life through the Marketplace? Genome Editing and the Commercialization of Academic Research in South Korea

  2021cites this paper
• How regulatory issues surrounding new breeding technologies can impact smallholder farmer breeding: A case study from the Philippines

  2021cites this paper
• Strategic framing of genome editing in agriculture: an analysis of the debate in Germany in the run-up to the European Court of Justice ruling

  2021cites this paper
• Trends of CRISPR technology development and deployment into Agricultural Production-Consumption Systems

  2020cites this paper
• Use of CRISPR in Climate Smart/Resilient Agriculture

  2020cites this paper
• Catalyzing Holistic Agriculture Innovation Through Industrial Biotechnology

  2020cites this paper
• Performativity of expectations

  2020cites this paper
• Performativity of expectations: The emergence of plant gene editing technologies in Japan

  2020cites this paper
• Moderne Konzepte der Nanobiotechnologie für mRNA‐Abgabesysteme

  2020cites this paper
• Can effectoromics and loss-of-susceptibility be exploited for improving Fusarium head blight resistance in wheat?

  2020cites this paper
• Progresses, Challenges, and Prospects of Genome Editing in Soybean (Glycine max)

  2020cites this paper
• Precision Technologies for Agriculture: Digital Farming, Gene-Edited Crops, and the Politics of Sustainability

  2020cites this paper
• Assessment of Gene Flow to Wild Relatives and Nutritional Composition of Sugarcane in Brazil

  2020cites this paper
• Research on the Integrated Development of Innovation and Entrepreneurship Education for College Students in the Era of Mass Entrepreneurship and Innovation

  2020cites this paper
• Plant Genome Editing – Policies and Governance

  2020cites this paper
• Emerging concepts of nanobiotechnology in mRNA delivery.

  2020cites this paper
• Genome editing with the CRISPR‐Cas system: an art, ethics and global regulatory perspective

  2020cites this paper
• Emergent challenges for CRISPR: biosafety, biosecurity, patenting, and regulatory issues

  2020cites this paper
• A comparison of the EU regulatory approach to directed mutagenesis with that of other jurisdictions, consequences for international trade and potential steps forward.

  2019cites this paper
• Dealing With Rejection: An Application of the Exit–Voice Framework to Genome-Edited Food

  2019cites this paper
• The application of the CRISPR-Cas9 genome editing machinery in food and agricultural science: Current status, future perspectives, and associated challenges.

  2019cites this paper
• CRISPR Ethics: Moral Considerations for Applications of a Powerful Tool.

  2019cites this paper
• Biomimetics for business? Industry perceptions and patent application

  2019cites this paper
• Modern Trends in Plant Genome Editing: An Inclusive Review of the CRISPR/Cas9 Toolbox

  2019cites this paper
• Worldwide CRISPR patent landscape shows strong geographical biases

  2019cites this paper
• CRISPR/Cas in Arabidopsis: overcoming challenges to accelerate improvements in crop photosynthetic efficiencies.

  2019cites this paper
• CRISPR/Cas9 and CAR-T cell, collaboration of two revolutionary technologies in cancer immunotherapy, an instruction for successful cancer treatment.

  2018cites this paper
• The Swedish policy approach to directed mutagenesis in a European context.

  2018cites this paper
• Implementing CRISPR-Cas technologies in conventional and non-conventional yeasts: Current state and future prospects.

  2018cites this paper
• Snipping around for food: Economic, ethical and policy implications of CRISPR/Cas genome editing

  2018cites this paper
• Trends in Synthetic Biology Applications, Tools, Industry, and Oversight and Their Security Implications

  2018cites this paper
• CRISPR-Cas systems: ushering in the new genome editing era

  2018influential citation
• Degrowth, organic agriculture and GMOs: A reply to Gomiero (2017, JCLEPRO)

  2017cites this paper
• Falling giants and the rise of gene editing: ethics, private interests and the public good

  2017cites this paper